P. Potter

发表

Targeting oxidative stress in embryonal rhabdomyosarcoma.

Heather L. Mulder, Erin K. Hedlund, Sara M. Federico, 2013, Cancer cell.

p53-Mediated Regulation of Expression of a Rabbit Liver Carboxylesterase Confers Sensitivity to 7-Ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11)

M. Wierdl, C. Morton, P. Potter, 2003, Journal of Pharmacology and Experimental Therapeutics.

Carboxylesterase-mediated sensitization of human tumor cells to CPT-11 cannot override ABCG2-mediated drug resistance.

M. Wierdl, C. Morton, P. Potter, 2003, Molecular pharmacology.

Sudemycin E influences alternative splicing and changes chromatin modifications

S. Stamm, Yvonne N Fondufe-Mittendorf, C. Horbinski, 2014, Nucleic acids research.

In Silico Design and Evaluation of Carboxylesterase Inhibitors.

P. Potter, R. M. Wadkins, Xiaozhen Yu, 2010, Journal of pest science.

Mammalian carboxylesterases: from drug targets to protein therapeutics.

M. Redinbo, P. Potter, 2005, Drug discovery today.

The development and application of small molecule modulators of SF3b as therapeutic agents for cancer.

P. Potter, Amanda S. Joyner, T. Webb, 2013, Drug discovery today.

Use of the ornithine decarboxylase promoter to achieve N-MYC-mediated overexpression of a rabbit carboxylesterase to sensitize neuroblastoma cells to CPT-11.

P. Potter, S. Guichard, M. Danks, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

Tumour‐selective targeting of drug metabolizing enzymes to treat metastatic cancer

M. Wierdl, L. Tsurkan, P. Potter, 2016, British journal of pharmacology.

Overexpression of a rabbit liver carboxylesterase sensitizes human tumor cells to CPT-11.

C. Morton, P. Potter, M. Danks, 1998, Cancer research.

Comparison of activation of CPT-11 by rabbit and human carboxylesterases for use in enzyme/prodrug therapy.

P. Houghton, C. Morton, P. Potter, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Isolation and characterization of a cDNA encoding a horse liver butyrylcholinesterase: evidence for CPT-11 drug activation.

M. Wierdl, C. Morton, P. Potter, 2000, Biochemical pharmacology.

ATP-dependent Mitochondrial Porphyrin Importer ABCB6 Protects against Phenylhydrazine Toxicity*

J. Rehg, P. Potter, J. Schuetz, 2012, The Journal of Biological Chemistry.

Clinical genome sequencing uncovers potentially targetable truncations and fusions of MAP3K8 in spitzoid and other melanomas

Heather L. Mulder, J. Downing, S. Shurtleff, 2019, Nature Medicine.

Isolation and partial characterization of a cDNA encoding a rabbit liver carboxylesterase that activates the prodrug irinotecan (CPT-11).

C. Morton, P. Potter, M. Danks, 1998, Cancer research.

Optimization of a Neural Stem-Cell-Mediated Carboxylesterase/Irinotecan Gene Therapy for Metastatic Neuroblastoma

R. Moats, P. Potter, R. Seeger, 2016, Molecular therapy oncolytics.

Neural Stem Cell‐Mediated Delivery of Irinotecan‐Activating Carboxylesterases to Glioma: Implications for Clinical Use

L. Ghoda, P. Potter, Christine E. Brown, 2013, Stem cells translational medicine.

Water soluble 20(S)-glycinate esters of 10,11-methylenedioxycamptothecins are highly active against human breast cancer xenografts.

D. V. Von Hoff, G. Mangold, P. Potter, 1999, Cancer research.

Development of a Tumor-Selective Approach to Treat Metastatic Cancer

P. Potter, M. Danks, J. Remack, 2006, PloS one.

Proficient metabolism of irinotecan by a human intestinal carboxylesterase.

C. Morton, P. Potter, M. Danks, 2000, Cancer research.

Sudemycins, novel small molecule analogues of FR901464, induce alternative gene splicing.

P. Potter, T. Webb, Chandraiah Lagisetti, 2011, ACS chemical biology.

Inhibition of carboxylesterase-1 alters clopidogrel metabolism and disposition

P. Potter, S. Laizure, Zhe-yi Hu, 2020, Xenobiotica; the fate of foreign compounds in biological systems.

Sensitization of human tumor cells to CPT-11 via adenoviral-mediated delivery of a rabbit liver carboxylesterase.

M. Wierdl, C. Morton, P. Potter, 2001, Cancer research.

Hydrolysis of pyrethroids by human and rat tissues: examination of intestinal, liver and serum carboxylesterases.

P. Potter, M. Ross, J. Crow, 2007, Toxicology and applied pharmacology.

Mouse serum paraoxonase-1 lactonase activity is specific for medium-chain length fatty acid lactones.

P. Potter, P. Connelly, D. Ng, 2011, Biochimica et Biophysica Acta.

Inhibition of carboxylesterase activity of THP1 monocytes/macrophages and recombinant human carboxylesterase 1 by oxysterols and fatty acids.

P. Potter, M. Ross, J. Crow, 2010, Biochimica et biophysica acta.

Brain tumor oncolysis with replication-conditional herpes simplex virus type 1 expressing the prodrug-activating genes, CYP2B1 and secreted human intestinal carboxylesterase, in combination with cyclophosphamide and irinotecan.

D. Finkelstein, P. Potter, M. Danks, 2005, Cancer research.

Inactivation of lipid glyceryl ester metabolism in human THP1 monocytes/macrophages by activated organophosphorus insecticides: role of carboxylesterases 1 and 2.

P. Potter, M. Ross, A. Borazjani, 2010, Chemical research in toxicology.

Exploiting a water network to achieve enthalpy-driven, bromodomain-selective BET inhibitors.

S. Knapp, M. Roussel, Taosheng Chen, 2018, Bioorganic & medicinal chemistry.

Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping

Michael C. Rusch, Michael N. Edmonson, M. Edmonson, 2018, RNA.

Global and local molecular dynamics of a bacterial carboxylesterase provide insight into its catalytic mechanism

S. Gwaltney, M. Wierdl, P. Potter, 2012, Journal of Molecular Modeling.

Advances in Brief Ribozyme-mediated Modulation of Human 06-Methylguanine-DNA Methyltransferase Expression 1

Thomas, P. Potter, L. Harris, 2006 .

A virus-directed enzyme prodrug therapy approach to purging neuroblastoma cells from hematopoietic cells using adenovirus encoding rabbit carboxylesterase and CPT-11.

M. Wierdl, P. Potter, S. Guichard, 2001, Cancer research.

Adenovirus Encoding Rabbit Carboxylesterase and CPT-11 Purging Neuroblastoma Cells from Hematopoietic Cells Using A Virus-directed Enzyme Prodrug Therapy Approach to Updated

M. Wierdl, P. Potter, S. Guichard, 2001 .

Activation of CPT-11 in mice: identification and analysis of a highly effective plasma esterase.

M. Wierdl, C. Morton, P. Potter, 2000, Cancer research.

Ribozyme-mediated modulation of human O6-methylguanine-DNA methyltransferase expression.

P. Potter, L. Harris, J. Remack, 1993, Cancer research.

Isolation and partial characterisation of a Chinese hamster O6-alkylguanine-DNA alkyltransferase cDNA.

P. Potter, A. Watson, L. Cawkwell, 1992, Nucleic acids research.

Human carboxylesterase 1: from drug metabolism to drug discovery.

M. Redinbo, P. Potter, S. Bencharit, 2003, Biochemical Society transactions.

An improved human carboxylesterase for enzyme/prodrug therapy with CPT-11

P. Houghton, M. Redinbo, M. Wierdl, 2008, Cancer Gene Therapy.

Characterization of inhibitors of specific carboxylesterases: development of carboxylesterase inhibitors for translational application.

C. Morton, P. Potter, M. Danks, 2004, Molecular cancer therapeutics.

Crystal structures of human carboxylesterase 1 in covalent complexes with the chemical warfare agents soman and tabun.

M. Redinbo, P. Potter, D. Cerasoli, 2007, Biochemistry.

Irinotecan , in Combination with Cyclophosphamide Carboxylesterase Secreted Human Intestinal and CYP 2 B 1 Genes , Simplex Virus Type 1 Expressing the Prodrug-Activating Brain Tumor Oncolysis with Replication-Conditional Herpes

D. Finkelstein, P. Potter, M. Danks, 2005 .

High payload dual therapeutic-imaging nanocarriers for triggered tumor delivery.

Jingxin Nie, P. Potter, J. Rinehart, 2012, Small.

Cellular localization domains of a rabbit and a human carboxylesterase: influence on irinotecan (CPT-11) metabolism by the rabbit enzyme.

M. Wierdl, C. Morton, P. Potter, 1998, Cancer research.

Species Differences in the in Vitro Metabolism of Deltamethrin and Esfenvalerate: Differential Oxidative and Hydrolytic Metabolism by Humans and Rats

M. DeVito, P. Potter, M. Ross, 2006, Drug Metabolism and Disposition.

Efficacy and toxicity of a virus-directed enzyme prodrug therapy purging method: preclinical assessment and application to bone marrow samples from neuroblastoma patients.

P. Houghton, C. Morton, P. Potter, 2002, Cancer research.

Activation and antitumor activity of CPT-11 in plasma esterase-deficient mice

P. Houghton, C. Morton, P. Potter, 2005, Cancer Chemotherapy and Pharmacology.

Construction of adenovirus for high level expression of small RNAs in mammalian cells

C. Morton, P. Potter, P. McKenzie, 2000, Molecular biotechnology.

Identification of human intestinal carboxylesterase as the primary enzyme for activation of a doxazolidine carbamate prodrug.

P. Potter, T. Koch, C. Edwards, 2008, Journal of medicinal chemistry.

Identification of the cross-link between human O6-methylguanine-DNA methyltransferase and chloroethylnitrosourea-treated DNA.

P. E. Gonzaga, G. Margison, P. Potter, 1992, Cancer research.

The crystal structure of the complex of the anticancer prodrug CPT-11 with Torpedo acetylcholinesterase provides a molecular explanation for its cholinergic action Fast

J. Sussman, I. Silman, M. Harel, 2005 .

Structural insights into drug processing by human carboxylesterase 1: tamoxifen, mevastatin, and inhibition by benzil.

Sompop Bencharit, M. Redinbo, C. Morton, 2005, Journal of molecular biology.

Toxicology and Biodistribution Studies for MGH2.1, an Oncolytic Virus that Expresses Two Prodrug-activating Genes, in Combination with Prodrugs

E. Chiocca, P. Potter, M. Phelps, 2013, Molecular therapy. Nucleic acids.

Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1.

R. K. Guy, P. Potter, M. Danks, 2007, Journal of medicinal chemistry.

Analysis of the inhibition of mammalian carboxylesterases by novel fluorobenzoins and fluorobenzils.

M. Wierdl, P. Potter, R. M. Wadkins, 2007, Bioorganic & medicinal chemistry.

Inhibition of carboxylesterases by benzil (diphenylethane-1,2-dione) and heterocyclic analogues is dependent upon the aromaticity of the ring and the flexibility of the dione moiety.

M. Zeller, A. D. Hunter, M. Wierdl, 2005, Journal of medicinal chemistry.

Modulation of esterified drug metabolism by tanshinones from Salvia miltiorrhiza ("Danshen").

P. Potter, A. Lemoff, C. Jeffries, 2013, Journal of natural products.

Inhibition of human carboxylesterases hCE1 and hiCE by cholinesterase inhibitors.

P. Potter, Carol C Edwards, Philip M Potter, 2013, Chemico-biological interactions.

The anticancer prodrug CPT-11 is a potent inhibitor of acetylcholinesterase but is rapidly catalyzed to SN-38 by butyrylcholinesterase.

C. Morton, P. Potter, M. Danks, 1999, Cancer research.

Butyrylcholinesterase Acetylcholinesterase but Is Rapidly Catalyzed to SN-38 by The Anticancer Prodrug CPT-11 Is a Potent Inhibitor of Updated Version

C. Morton, P. Potter, M. Danks, 1999 .

Selective Inhibitors of Human Liver Carboxylesterase Based on a β-Lapachone Scaffold: Novel Reagents for Reaction Profiling.

P. Potter, J. Bowling, C. Jeffries, 2017, Journal of medicinal chemistry.

Structural basis of heroin and cocaine metabolism by a promiscuous human drug-processing enzyme

Matthew R. Redinbo, Sompop Bencharit, Christopher L. Morton, 2003, Nature Structural Biology.

Structural insights into CPT-11 activation by mammalian carboxylesterases

M. Redinbo, C. Morton, P. Potter, 2002, Nature Structural Biology.

Hydrolytic metabolism of pyrethroids by human and other mammalian carboxylesterases.

P. Potter, M. Ross, Matthew K Ross, 2006, Biochemical pharmacology.

Carboxylesterases: General detoxifying enzymes.

Michael R. Taylor, M. Wierdl, L. Tsurkan, 2016, Chemico-biological interactions.

Requirements for mammalian carboxylesterase inhibition by substituted ethane-1,2-diones.

Elizabeth I. Parkinson, P. Potter, B. Yan, 2011, Bioorganic & medicinal chemistry.

Analysis of Mammalian Carboxylesterase Inhibition by Trifluoromethylketone-Containing Compounds

Bruce D. Hammock, Matthew R. Redinbo, Paul D. Jones, 2007, Molecular Pharmacology.

Discovery of novel selective inhibitors of human intestinal carboxylesterase for the amelioration of irinotecan-induced diarrhea: synthesis, quantitative structure-activity relationship analysis, and biological activity.

P. Beroza, C. Morton, P. Potter, 2004, Molecular pharmacology.

Challenges and Opportunities with Non-CYP Enzymes Aldehyde Oxidase, Carboxylesterase, and UDP-Glucuronosyltransferase: Focus on Reaction Phenotyping and Prediction of Human Clearance

P. Potter, P. Marathe, J. M. Hutzler, 2016, The AAPS Journal.

Organ-specific carboxylesterase profiling identifies the small intestine and kidney as major contributors of activation of the anticancer prodrug CPT-11.

P. Potter, T. Shaver, C. Edwards, 2011, Biochemical pharmacology.

Selective inhibition of carboxylesterases by isatins, indole-2,3-diones.

M. Wierdl, P. Potter, M. Danks, 2007, Journal of medicinal chemistry.

Intracellular inhibition of carboxylesterases by benzil: modulation of CPT-11 cytotoxicity

M. Wierdl, P. Potter, M. Danks, 2006, Molecular Cancer Therapeutics.

Carboxylesterases--detoxifying enzymes and targets for drug therapy.

P. Potter, R. M. Wadkins, 2006, Current medicinal chemistry.

Identification and characterization of novel benzil (diphenylethane-1,2-dione) analogues as inhibitors of mammalian carboxylesterases.

P. Beroza, M. Wierdl, C. Morton, 2005, Journal of medicinal chemistry.

Comparison of Escherichia coli, Saccharomyces cerevisiae, Pichia pastoris, Spodoptera frugiperda, and COS7 cells for recombinant gene expression

C. Morton, P. Potter, 2000, Molecular biotechnology.

Conversion of the CPT-11 metabolite APC to SN-38 by rabbit liver carboxylesterase.

C. Morton, P. Potter, S. Guichard, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Structural constraints affect the metabolism of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) by carboxylesterases.

M. Wierdl, C. Morton, P. Potter, 2001, Molecular pharmacology.

Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: from binding promiscuity to selective inhibition.

P. Kuhn, M. Redinbo, C. Morton, 2003, Chemistry & biology.

Evaluation of the ‘side door’ in carboxylesterase-mediated catalysis and inhibition

S. Gwaltney, M. Wierdl, P. Potter, 2008, Biological chemistry.

Potent, Irreversible Inhibition of Human Carboxylesterases by Tanshinone Anhydrides Isolated from Salvia miltiorrhiza ("Danshen").

P. Potter, J. Bowling, M. Hatfield, 2018, Journal of natural products.

Carboxylesterase inhibitors

P. Potter, M. Hatfield, 2011, Expert opinion on therapeutic patents.

The Crystal Structure of the Complex of the Anticancer Prodrug 7-Ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin (CPT-11) with Torpedo californica Acetylcholinesterase Provides a Molecular Explanation for Its Cholinergic Action

J. Sussman, I. Silman, M. Harel, 2005, Molecular Pharmacology.

Inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by chlorpyrifos oxon, paraoxon and methyl paraoxon.

P. Potter, M. Ross, J. Crow, 2012, Toxicology and applied pharmacology.

Structure-activity relationships of substituted 1-pyridyl-2-phenyl-1,2-ethanediones: potent, selective carboxylesterase inhibitors.

Taosheng Chen, David C. Bouck, P. Potter, 2010, Journal of medicinal chemistry.

Inhibition of carboxylesterase 1 is associated with cholesteryl ester retention in human THP-1 monocyte/macrophages.

P. Potter, M. Ross, J. Crow, 2008, Biochimica et biophysica acta.

Improved, selective, human intestinal carboxylesterase inhibitors designed to modulate 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (Irinotecan; CPT-11) toxicity.

P. Potter, R. M. Wadkins, Shana V. Stoddard, 2009, Journal of medicinal chemistry.

Facile synthesis of 1,2-dione-containing abietane analogues for the generation of human carboxylesterase inhibitors.

P. Potter, M. Hatfield, Liying Chi, 2018, European journal of medicinal chemistry.

Covalent inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by the carbamates JZL184 and URB597.

P. Potter, M. Ross, J. Crow, 2012, Biochemical pharmacology.

Comparison of benzil and trifluoromethyl ketone (TFK)-mediated carboxylesterase inhibition using classical and 3D-quantitative structure-activity relationship analysis.

P. Potter, C. Wheelock, Y. Nakagawa, 2009, Bioorganic & medicinal chemistry.

Modifications of human carboxylesterase for improved prodrug activation

M. Wierdl, P. Potter, R. M. Wadkins, 2008, Expert opinion on drug metabolism & toxicology.

Development of an etoposide prodrug for dual prodrug-enzyme antitumor therapy

P. Potter, M. Danks, J. Remack, 2006, Molecular Cancer Therapeutics.

Inhibition of acetylcholinesterase by the anticancer prodrug CPT-11.

J. Sussman, I. Silman, M. Harel, 2005, Chemico-biological interactions.

Activation of a camptothecin prodrug by specific carboxylesterases as predicted by quantitative structure-activity relationship and molecular docking studies.

C. Morton, P. Potter, M. Danks, 2003, Molecular cancer therapeutics.

Control of RhoA Methylation by Carboxylesterase I*

P. Casey, P. Potter, I. Cushman, 2013, The Journal of Biological Chemistry.

Correction: Nerve Agent Hydrolysis Activity Designed into a Human Drug Metabolism Enzyme

S. L. Mayo, J. Cashman, M. Redinbo, 2012, PLoS ONE.

Nerve Agent Hydrolysis Activity Designed into a Human Drug Metabolism Enzyme

S. L. Mayo, J. Cashman, M. Redinbo, 2011, PloS one.

Human Carboxylesterase 1 Stereoselectively Binds the Nerve Agent Cyclosarin and Spontaneously Hydrolyzes the Nerve Agent Sarin

J. Cashman, M. Redinbo, M. Wierdl, 2010, Molecular Pharmacology.

Microsoft Word-40103400-file00

J. Cashman, M. Redinbo, M. Wierdl, 2010 .

Structural and Biochemical Analysis Reveals the Stereoselectivity of Inhibition and Reactivation of Human Carboxylesterase 1 for the Nerve Agents Sarin, Soman, and Cyclosarin.

J. Cashman, M. Redinbo, M. Wierdl, 2010 .

Multisite promiscuity in the processing of endogenous substrates by human carboxylesterase 1.

Peter Kuhn, Sompop Bencharit, P. Kuhn, 2006, Journal of molecular biology.

Synthesis and evaluation of esters and carbamates to identify critical functional groups for esterase-specific metabolism.

C. Morton, P. Potter, M. Danks, 2003, Bioorganic & medicinal chemistry.

In situ subcellular localization of epitope-tagged human and rabbit carboxylesterases.

C. Morton, P. Potter, M. Danks, 1998, Cytometry.

Repair of O-alkylpyrimidines in mammalian cells: a present consensus.

H. Fraenkel-conrat, M. Dolan, G. Margison, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Purification of the E. coli ogt gene product to homogeneity and its rate of action on O6-methylguanine, O6-ethylguanine and O4-methylthymine in dodecadeoxyribonucleotides.

G. Margison, P. Potter, P. Georgiadis, 1989, Nucleic acids research.

Characterisation and nucleotide sequence of ogt, the O6-alkylguanine-DNA-alkyltransferase gene of E. coli.

D. Cooper, G. Margison, P. Potter, 1987, Nucleic acids research.

Tissue‐specific expression and induction of human O6‐alkylguanine‐dna alkyltransferase in transgenic mice

G. Margison, P. Potter, C. Fan, 1992, Molecular carcinogenesis.

Characterization of the promoter region of the human O6-methylguanine-DNA methyltransferase gene.

P. Potter, L. Harris, T. Brent, 1991, Nucleic acids research.

Immunohistological examination of the inter- and intracellular distribution of O6-alkylguanine DNA-alkyltransferase in human liver and melanoma.

P. Potter, C. Fan, H. Altermatt, 1992, British Journal of Cancer.

Pharmacodynamic assays to facilitate preclinical and clinical development of pre-mRNA splicing modulatory drug candidates

S. Stamm, P. Potter, Amanda S. Joyner, 2015, Pharmacology research & perspectives.

Enzyme-Prodrug Systems

P. Potter, M. Danks, 2004 .

Targeting ALK in pediatric RMS does not induce antitumor activity in vivo

Chunxu Qu, Xiang Chen, M. Wierdl, 2018, Cancer Chemotherapy and Pharmacology.

Use of a modified ornithine decarboxylase promoter to achieve efficient c-MYC- or N-MYC-regulated protein expression.

P. Potter, M. Danks, L. Harris, 2001, Cancer research.

Expression Achieve Efficient c-MYC-or N-MYC-regulated Protein Use of a Modified Ornithine Decarboxylase Promoter to Updated Version

P. Potter, M. Danks, L. Harris, 2001 .

A comparison of human O6-methylguanine-DNA methyltransferase promoter activity in Mer+ and Mer- cells.

P. Potter, L. Harris, J. Remack, 1992, Cancer research.

Expression of a human O6-alkylguanine-DNA-alkyltransferase cDNA in human cells and transgenic mice.

G. Margison, P. Potter, C. Fan, 1990, Nucleic acids research.

A prodrug strategy using ONYX-015-based replicating adenoviruses to deliver rabbit carboxylesterase to tumor cells for conversion of CPT-11 to SN-38.

L. Johnson, M. Lemmon, A. Fattaey, 2003, Cancer research.

Targeting the DNA repair pathway in Ewing sarcoma.

Abbas Shirinifard, Elizabeth Stewart, Andras Sablauer, 2014, Cell reports.

Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma.

M. Wierdl, L. Tsurkan, P. Potter, 2007, Cancer research.

Rhabdomyosarcoma-specific expression of the herpes simplex virus thymidine kinase gene confers sensitivity to ganciclovir.

C. Morton, P. Potter, 1998, The Journal of pharmacology and experimental therapeutics.

The 3D structure of the anticancer prodrug CPT-11 with Torpedo californica acetylcholinesterase rationalizes its inhibitory action on AChE and its hydrolysis by butyrylcholinesterase and carboxylesterase.

J. Sussman, I. Silman, M. Harel, 2005, Chemico-biological interactions.

Isolation and cDNA cloning of a rat O6-alkylguanine-DNA-alkyltransferase gene, molecular analysis of expression in rat liver.

D. Cooper, G. Margison, P. Potter, 1991, Carcinogenesis.

Expression of a human 06-alkylguanine-DNA-alkyltransferase cDNA in human cells and transgenic mice

P. Potter, P. Searle, A. Watson, 2022 .

Purification to homogeneity of a human DNA repair protein using an alternative to DNA-affinity chromatography

P. Potter, T. Brent, A. Lassiter, 1993 .

Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric Cancer

M. Roussel, Taosheng Chen, A. Shelat, 2020, Cancer Research.

Clinical genome sequencing uncovers potentially targetable truncations and fusions of MAP3K8 in spitzoid and other melanomas

Heather L. Mulder, J. Downing, S. Shurtleff, 2019, Nature Medicine.

Therapeutic targeting of melanoma cells using neural stem cells expressing carboxylesterase, a CPT-11 activating enzyme.

P. Potter, Seung U. Kim, K. Aboody, 2010, Current stem cell research & therapy.

Immobilization of active human carboxylesterase 1 in biomimetic silica nanoparticles

M. Redinbo, P. Potter, A. Kumbhar, 2011, Biotechnology progress.

Development of prodrugs for enzyme-mediated, tumor-selective therapy.

P. Potter, M. Danks, K. J. Yoon, 2005, Current Medicinal Chemistry - Anti-Cancer Agents.

Structural basis of heroin and cocaine metabolism by a promiscuous human drug-processing enzyme

M. Redinbo, C. Morton, P. Potter, 2003, Nature Structural Biology.

Biochemical and molecular analysis of carboxylesterase‐mediated hydrolysis of cocaine and heroin

L. Tsurkan, P. Potter, R. M. Wadkins, 2010, British journal of pharmacology.

Enzyme-prodrug systems: carboxylesterase/CPT-11.

P. Potter, M. Danks, 2004, Methods in molecular medicine.

Metabolism of 2-naphthylamine and benzidine by rat and human bladder organ cultures.

P. Potter, R. M. Hicks, B. Moore, 1984, Carcinogenesis.